Bernd Nosse currently serves as Global Head of Business Development and Licensing for Research Beyond Borders & Technologies at Boehringer Ingelheim, a position held since March 2020, focusing on strategic partnerships in gene therapy, regenerative medicine, and infectious diseases. Prior to this role, Bernd Nosse held the position of Global Head BD&L Technologies at Boehringer Ingelheim from January 2006 to March 2020, concentrating on enabling technologies for the Innovation Unit. Additional experience includes leadership roles in medicinal chemistry and research, having started as a Senior Research Scientist and progressed to Director of Medicinal Chemistry. Bernd Nosse's academic credentials include a postdoctoral fellowship at UC Irvine and a PhD from the University of Regensburg, specializing in total synthesis of natural products.
This person is not in the org chart
This person is not in any teams
This person is not in any offices